A detailed history of Concentric Capital Strategies, LP transactions in Abb Vie Inc. stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 8,392 shares of ABBV stock, worth $1.51 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
8,392
Previous 5,639 48.82%
Holding current value
$1.51 Million
Previous $967,000 71.35%
% of portfolio
0.07%
Previous 0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $451,051 - $548,755
2,753 Added 48.82%
8,392 $1.66 Million
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $872,860 - $1.02 Million
5,639 New
5,639 $967,000
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $457,278 - $529,366
3,423 New
3,423 $510,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $1.71 Million - $1.97 Million
11,838 New
11,838 $1.89 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Concentric Capital Strategies, LP Portfolio

Follow Concentric Capital Strategies, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concentric Capital Strategies, LP, based on Form 13F filings with the SEC.

News

Stay updated on Concentric Capital Strategies, LP with notifications on news.